• Something wrong with this record ?

Variation in Current Management of Term and Late-preterm Neonates at Risk for Early-onset Sepsis: An International Survey and Review of Guidelines

W. van Herk, S. el Helou, J. Janota, C. Hagmann, C. Klingenberg, E. Staub, E. Giannoni, P. Tissieres, LJ. Schlapbach, AM. van Rossum, SB. Pilgrim, M. Stocker,

. 2016 ; 35 (5) : 494-500.

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17000646

BACKGROUND: Uncertainty about the presence of infection results in unnecessary and prolonged empiric antibiotic treatment of newborns at risk for early-onset sepsis (EOS). This study evaluates the impact of this uncertainty on the diversity in management. METHODS: A web-based survey with questions addressing management of infection risk-adjusted scenarios was performed in Europe, North America, and Australia. Published national guidelines (n = 5) were reviewed and compared with the results of the survey. RESULTS: 439 Clinicians (68% were neonatologists) from 16 countries completed the survey. In the low-risk scenario, 29% would start antibiotic therapy and 26% would not, both groups without laboratory investigations; 45% would start if laboratory markers were abnormal. In the high-risk scenario, 99% would start antibiotic therapy. In the low-risk scenario, 89% would discontinue antibiotic therapy before 72 hours. In the high-risk scenario, 35% would discontinue therapy before 72 hours, 56% would continue therapy for 5-7 days, and 9% for more than 7 days. Laboratory investigations were used in 31% of scenarios for the decision to start, and in 72% for the decision to discontinue antibiotic treatment. National guidelines differ considerably regarding the decision to start in low-risk and regarding the decision to continue therapy in higher risk situations. CONCLUSIONS: There is a broad diversity of clinical practice in management of EOS and a lack of agreement between current guidelines. The results of the survey reflect the diversity of national guidelines. Prospective studies regarding management of neonates at risk of EOS with safety endpoints are needed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000646
003      
CZ-PrNML
005      
20200121110118.0
007      
ta
008      
170103s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/INF.0000000000001063 $2 doi
024    7_
$a 10.1097/INF.0000000000001063 $2 doi
035    __
$a (PubMed)26766143
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a van Herk, Wendy $u From the *Division of Infectious Diseases and Immunology, Department of Pediatrics, Erasmus MC University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands; †Division of Neonatology, McMaster University Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada; ‡Department of Neonatology, Thomayer Hospital, Prague, Czech Republic; §Institute of Pathological Physiology, First Medical Faculty, Charles University in Prague, Czech Republic; ¶University Hospital Zurich, Zurich, Switzerland; ‖Department of Paediatrics, University Hospital of North Norway, Tromsø, Norway; **Paediatric Research Group, Faculty of Health Sciences, University of Tromsø-Arctic University of Norway, Tromsø, Norway; ††Department of Neonatology, The Children's Hospital at Westmead, New South Wales, Australia; ‡‡Service of Neonatology, University Hospital of Lausanne, Lausanne, Switzerland; §§Department of Pediatrics, Hôpitaux Universitaires Paris-Sud AP-HP, Le Kremlin-Bicêtre, France; ¶¶Paediatric Critical Care Research Group, Mater Research Institute, University of Queensland, Brisbane, Australia; ‖‖Department of Pediatrics, Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, Brisbane, Australia; ***Department of Pediatrics, University Children's Hospital Berne, Berne, Switzerland; and †††Department of Pediatrics, Children's Hospital Lucerne, Lucerne, Switzerland.
245    10
$a Variation in Current Management of Term and Late-preterm Neonates at Risk for Early-onset Sepsis: An International Survey and Review of Guidelines / $c W. van Herk, S. el Helou, J. Janota, C. Hagmann, C. Klingenberg, E. Staub, E. Giannoni, P. Tissieres, LJ. Schlapbach, AM. van Rossum, SB. Pilgrim, M. Stocker,
520    9_
$a BACKGROUND: Uncertainty about the presence of infection results in unnecessary and prolonged empiric antibiotic treatment of newborns at risk for early-onset sepsis (EOS). This study evaluates the impact of this uncertainty on the diversity in management. METHODS: A web-based survey with questions addressing management of infection risk-adjusted scenarios was performed in Europe, North America, and Australia. Published national guidelines (n = 5) were reviewed and compared with the results of the survey. RESULTS: 439 Clinicians (68% were neonatologists) from 16 countries completed the survey. In the low-risk scenario, 29% would start antibiotic therapy and 26% would not, both groups without laboratory investigations; 45% would start if laboratory markers were abnormal. In the high-risk scenario, 99% would start antibiotic therapy. In the low-risk scenario, 89% would discontinue antibiotic therapy before 72 hours. In the high-risk scenario, 35% would discontinue therapy before 72 hours, 56% would continue therapy for 5-7 days, and 9% for more than 7 days. Laboratory investigations were used in 31% of scenarios for the decision to start, and in 72% for the decision to discontinue antibiotic treatment. National guidelines differ considerably regarding the decision to start in low-risk and regarding the decision to continue therapy in higher risk situations. CONCLUSIONS: There is a broad diversity of clinical practice in management of EOS and a lack of agreement between current guidelines. The results of the survey reflect the diversity of national guidelines. Prospective studies regarding management of neonates at risk of EOS with safety endpoints are needed.
650    _2
$a Austrálie $7 D001315
650    12
$a koordinovaný terapeutický postup $7 D019090
650    _2
$a Evropa $7 D005060
650    12
$a dodržování směrnic $7 D019983
650    12
$a směrnice jako téma $7 D017408
650    _2
$a zdravotní politika $7 D006291
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a novorozenecká sepse $x diagnóza $x terapie $7 D000071074
650    _2
$a Severní Amerika $7 D009656
650    _2
$a průzkumy a dotazníky $7 D011795
655    _2
$a časopisecké články $7 D016428
700    1_
$a el Helou, Salhab
700    1_
$a Janota, Jan
700    1_
$a Hagmann, Cornelia
700    1_
$a Klingenberg, Claus
700    1_
$a Staub, Eveline
700    1_
$a Giannoni, Eric
700    1_
$a Tissieres, Pierre
700    1_
$a Schlapbach, Luregn J
700    1_
$a van Rossum, Annemarie M C
700    1_
$a Pilgrim, Sina B
700    1_
$a Stocker, Martin
773    0_
$w MED00003732 $t The Pediatric infectious disease journal $x 1532-0987 $g Roč. 35, č. 5 (2016), s. 494-500
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26766143 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20200121110455 $b ABA008
999    __
$a ok $b bmc $g 1179786 $s 961213
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 35 $c 5 $d 494-500 $i 1532-0987 $m The Pediatric infectious disease journal $n Pediatr Infect Dis J $x MED00003732
LZP    __
$a Pubmed-20170103

Find record

Citation metrics

Archiving options